Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Guidance on when Traditional Budgeting is most appropriate, including typical use cases and factors to consider for your finances.
21,043 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Investors are watching canaan (can) 2026 earnings as CAN navigates a shifting mining market. This guide breaks down t...
A major hedge fund liquidated its GitLab position, prompting questions about strategy and market impact. This article...
Ralph Lauren faces a pivotal year in 2026. This article breaks down the brand's strategic moves, potential growth dri...
Sara Holtz, chief marketing officer at Optimal Blue, outlines a leadership playbook that uses AI to sharpen decision-...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
A Deloitte-recognized fastest-growing software firm opens the last phase of a pre-IPO funding round, offering micro-s...
When a major chip stock slips, it sparks questions about why the move happened and what it means for your plan. This ...
Salesforce unveiled a record $25 billion accelerated share repurchase funded by debt as it posted quarterly results. ...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...
Anterix stock surged 140% as a major investor disclosed a multi-million dollar buy. This article breaks down the driv...